L.S. Hofstra - Concepedia

Author

L.S. Hofstra

University Medical Center Groningen

Also Known As

L HOFSTRA, L S Hofstra, L S. Hofstra, L. Hofstra, L. S. Hofstra, L.S. Hofstra, LS Hofstra

Publications

674

Citations

H-Index

Concepts

All Affiliations

University Medical Center Groningen University of Groningen Slotervaartziekenhuis

About

L.S. Hofstra is an author at University Medical Center Groningen specializing in oncology, medicine, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	135
2	Obstetrics	3	3	78
3	Health Sciences	1	1	57
4	Allergy	1	1	57
5	Immunology	1	1	57

L.S. Hofstra

Publications

265

Citations

H-Index

Page 1

	Year	Citations
Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis. A.N.M. Wymenga, W T van der Graaf, L.S. Hofstra, PubMed ImmunologyOral MicrobiologyOral MedicineGrowth Factor-beta3 MouthwashesSalivary Gland	1999	57
Partial cell fusion: A newly recognized type of communication between dedifferentiating cardiomyocytes and fibroblasts Ronald B. Driesen, G Dispersyn, Fons Verheyen, Cardiovascular Research	2005	54
Intraperitoneal chemotherapy in ovarian cancer L.S. Hofstra, Elisabeth G.E. de Vries, Nanno H. Mulder, Cancer Treatment Reviews MedicineGynecologyMetronomic ChemotherapyOncologyGynecology Oncology	2000	39
A phase I and pharmacokinetic study of intraperitoneal topotecan L.S. Hofstra, A.M.E. Bos, Elisabeth G.E. de Vries, British Journal of Cancer	2001	28
Kinetic Modeling and Efficacy of Intraperitoneal Paclitaxel Combined with Intravenous Cyclophosphamide and Carboplatin as First-Line Treatment in Ovarian Cancer L.S. Hofstra, A.M.E. Bos, Elisabeth G.E. de Vries, Gynecologic Oncology Kinetic ModelingOncologyMedicineGynecologyPharmacotherapy	2002	24
Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report. BB Hanekamp, Jan G. Zijlstra, Jaap E. Tulleken, PubMed	2005	19
Combined treatment with goserelin and tamoxifen in patients with advanced chemotherapy resistant ovarian cancer. L.S. Hofstra, MJE Mourits, Elisabeth G.E. de Vries, PubMed	2000	17
Effect of Low-Dose Oral Etoposide on Serum CA-125 in Patients with Advanced Epithelial Ovarian Cancer Robert S. de Jong, L.S. Hofstra, Pax H.B. Willemse, Gynecologic Oncology Serum Ca-125Low-dose Oral EtoposideMedicineGynecologyCancer Treatment	1997	15
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma. L.S. Hofstra, Gunnar B. Kristensen, P.H.B. Willemse, Journal of Clinical Oncology	1998	12

Page 1